Polymorphisms in the CTLA‐4 gene and inhibitor development in patients with severe hemophilia A
Open Access
- 22 January 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (2), 263-265
- https://doi.org/10.1111/j.1538-7836.2007.02290.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophiliaHaemophilia, 2006
- Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia ABlood, 2006
- Haemophilia Inhibitor Genetics Study – evaluation of a model for studies of complex diseases using linkage and association methodsHaemophilia, 2005
- A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of proteinGenes & Immunity, 2002
- Association of CTLA‐4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese populationRheumatology, 2001
- CTLA-4 gene expression is influenced by promoter and exon 1 polymorphismsGenes & Immunity, 2001
- CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ DiseaseThe Journal of Immunology, 2000
- Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groupsHuman Molecular Genetics, 1997
- An Mse I RFLP in the Human CTLA4 PromotorBiochemical and Biophysical Research Communications, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995